NA-Semax & NA-Selank: Enhanced Nootropics

Category: Protocols Type: Protocol Read Time: 16 minutes Author: Peptides.NYC Editorial Last Updated: 2026-05-19 URL: https://peptides.nyc/learn/na-semax-selank-protocol

Educational content only. Not medical advice. Consult a licensed healthcare provider before starting any protocol.

Overview

N-Acetyl-Semax-amidate (NA-Semax) and N-Acetyl-Selank-amidate (NA-Selank) are structurally modified analogs of two well-known Russian neuropeptides. Both base molecules — Semax (an ACTH 4-10 fragment) and Selank (a tuftsin analog) — were developed within the Russian Academy of Medical Sciences and have circulated for decades as prescribed nootropics and anxiolytics in their country of origin.

The "NA" variants add two chemical modifications: an N-terminal acetyl group and a C-terminal amidation. Together these tweaks meaningfully increase peptide stability, half-life, and reported potency relative to the standard sequences.

Quick reference:

• NA-Semax = enhanced focus / drive / cognitive throughput analog
• NA-Selank = enhanced calm / anxiolytic / mood-stabilizing analog
• Most users report stronger and longer effects than base Semax/Selank
• Typically administered intranasally; injectable forms exist but are less common
• Sold as research chemicals outside of Russia; not FDA-approved

Where they fit in the nootropic landscape:

NA-Semax and NA-Selank occupy an unusual niche. Most popular nootropics either work fast and bluntly (caffeine, modafinil, amphetamines) or work slowly and subtly (lion's mane, racetams, citicoline). The NA peptides sit between those poles — fast enough to feel within an hour, but subtle enough that they rarely overshoot into stimulation or sedation. That positioning is why they have developed a loyal user base among knowledge workers and high-performers who dislike the side effects of conventional cognitive enhancers.

Why N-Acetyl + Amidate

Standard peptides are vulnerable at both ends. Aminopeptidases attack the N-terminus, while carboxypeptidases nibble at the C-terminus. Together these enzymes shorten the effective window of base Semax and Selank to minutes in some tissues.

The two NA modifications address both flanks:

1. N-terminal acetylation — adding an acetyl group to the N-terminus blocks aminopeptidase recognition, dramatically slowing enzymatic clipping.
2. C-terminal amidation — converting the terminal carboxyl group to an amide shields the C-terminus from carboxypeptidase activity and often increases receptor affinity.

The net result reported in user circles and limited published research:

• Longer duration of action per dose
• Lower required dose for comparable effect
• Slightly stronger subjective response at matched doses
• Similar side-effect profile to base versions

These modifications are not unique to Semax/Selank — N-acetylation and amidation are common medicinal-chemistry strategies used to extend peptide half-life across many classes. The same approach is applied to numerous endogenous peptides converted into commercial therapeutics.

It is worth noting that base Semax and Selank were developed at the Institute of Molecular Genetics (RAS) over several decades, with substantial Russian clinical research literature behind both compounds. The NA analogs were synthesized largely as research tools to probe receptor binding and pharmacokinetics — their use as consumer nootropics is a relatively recent phenomenon driven by the research-chemical market rather than formal regulatory pathways.

NA-Semax vs Standard Semax

Users transitioning from base Semax usually reduce their dose substantially when switching to NA-Semax to avoid overstimulation or rebound fatigue.

NA-Selank vs Standard Selank

Some users describe NA-Selank as producing a "benzo-like" reduction in acute anxiety — without the sedation, cognitive blunting, or dependence pattern associated with benzodiazepines. This is anecdotal, not established by controlled trials, and individual response varies considerably.

Dosing Protocols

Practical dosing notes:

• Start with the lowest realistic dose (1 spray) and assess response over 3-5 days before increasing.
• Intranasal sprays should be alternated between nostrils to reduce local irritation.
• Injectable forms require lower total doses for comparable effect due to bypassing nasal-mucosa losses.
• Do not combine sprays in the same nostril within 30 seconds — wait between applications.

Intranasal vs Injectable

Intranasal is the dominant route for both peptides for good reason — the olfactory pathway bypasses much of the blood-brain barrier, which is especially valuable for short peptides that would otherwise be degraded systemically. Most user-reported protocols and the limited Russian literature on the parent compounds use intranasal administration.

Injectable forms are typically used by people already comfortable with peptide injections, those wanting more reproducible plasma levels, or those experiencing nasal sensitivity.

Stacking Strategy

A common cognition + mood split:

• Morning: NA-Semax (1 spray each nostril) for focus, drive, and executive function during the work block.
• As needed: NA-Selank (1-2 sprays) for acute anxiety, social stress, or evening wind-down.
• Optional early afternoon: A second light NA-Semax dose (1 spray) to extend cognitive momentum without disrupting sleep.

Pairing options:

• + Cerebrolysin: Slower-onset neurotrophic support; pairs well for users seeking deeper, structural cognitive work over weeks. Stack carefully and on separate cycles.
• + Dihexa: Powerful angiotensin IV analog; use cautiously due to limited safety data and potency. Not a daily-driver pairing.
• + Methylene blue (low dose): Some users layer this for mitochondrial support; evidence is preliminary.

Avoid stacking NA-Semax with high-dose stimulants (e.g., prescription amphetamines) without medical supervision — additive sympathetic activation can amplify side effects.

Sample weekly structure for cognitive + mood support:

• Mon-Fri AM: NA-Semax 1-2 sprays after morning routine
• Mon-Fri midday: Optional NA-Semax 1 spray if work block extends
• Anytime PRN: NA-Selank 1-2 sprays before high-stress events
• Weekends: Lighter use or full off-days to preserve sensitivity

Expected Outcomes

NA-Semax — typical reported timeline:

• 15-30 minutes: subtle lift in focus, motivation, and verbal fluency
• 1-2 hours: peak cognitive effect; users report deeper task engagement
• 4-8 hours: gradual taper; some experience mild fatigue at the tail end
• Best for: knowledge work, writing, study sessions, decision-heavy days

NA-Selank — typical reported timeline:

• 30-60 minutes: noticeable reduction in baseline anxiety and rumination
• 2-4 hours: peak anxiolytic effect; mood lifts without sedation
• 4-6 hours: gradual return to baseline
• Best for: presentations, social events, high-stress meetings, sleep prep

Effects are generally subtle relative to pharmaceuticals — these are nootropics, not stimulants or sedatives. Users expecting Adderall-like surges or benzo-like sedation usually report disappointment.

Side Effects & Safety

Both NA variants are generally well-tolerated in user reports, though formal long-term safety data is limited.

Reported side effects:

• Mild nasal irritation or burning (intranasal)
• Headache (uncommon, usually dose-related)
• Fatigue (more common with NA-Semax at excessive doses)
• Mild emotional flatness (NA-Selank at high doses)
• Insomnia if NA-Semax is dosed too late in the day

Notably absent:

• No reported physical dependence pattern for either compound
• No documented withdrawal syndrome
• No tolerance crash on cessation in most user reports

Caveats:

• Long-term safety of the NA variants specifically is not well-characterized in the published literature; most safety inference comes from the base Semax/Selank Russian research base.
• Pregnancy, breastfeeding, and pediatric use have not been studied.
• People with seizure history, severe psychiatric conditions, or on MAOI/SSRI therapy should consult a clinician before use.

Cycling

The absence of obvious tolerance with these peptides means hard cycling is less essential than with, for example, GH secretagogues. Most users cycle conservatively to preserve sensitivity and confirm continued benefit.

Signs you may need a break:

• Subjective effect feels muted compared to your first 1-2 weeks
• Mild fatigue persists into the evening on dosing days
• Sleep onset becomes slightly delayed (NA-Semax specifically)
• You find yourself escalating dose to chase the original response

In any of these cases, a 1-2 week pause typically restores baseline sensitivity.

Frequently Asked Questions

Q: Is NA-Semax comparable to Adderall? A: No. NA-Semax produces subtle cognitive lift over hours, not a stimulant surge. It does not act on dopamine reuptake the way amphetamines do, and the subjective effect is more "smoother focus" than "amplified energy." Different category of compound entirely.

Q: Is NA-Selank a replacement for benzodiazepines? A: It is not equivalent and is not a clinical substitute. Some users report benzo-like acute anxiety reduction without sedation or dependence, but this is anecdotal. Anyone using benzodiazepines clinically should not adjust their regimen without their prescriber's involvement.

Q: Can I spray NA-Semax and NA-Selank in the same nostril? A: Best practice is to alternate nostrils and space doses 60-90 seconds apart so each peptide has time to absorb. Same-nostril back-to-back dosing can reduce uptake of the second compound.

Q: Are NA-Semax and NA-Selank safe long-term? A: There is no robust long-term human safety data on the NA variants specifically. Base Semax and Selank have decades of Russian clinical use without major safety signals, but extrapolation to the modified analogs is imperfect.

Q: How reliable is the supply chain — are counterfeits common? A: Yes, the counterfeit rate for NA-Semax and NA-Selank is reportedly high in the gray market. Underdosed sprays, mislabeled base versions sold as NA, and incorrect concentrations are all common complaints. Always request third-party COAs and buy from vendors with consistent batch testing.

Q: Do I build tolerance to either compound? A: Most users report minimal tolerance development, especially with intermittent or cycled use. Daily long-term users occasionally report diminished subjective effects, which usually resolve after a 1-2 week break.

Q: Can I combine NA-Semax with caffeine or nicotine? A: Most users do without issue. NA-Semax does not have the stimulant overlap that would cause obvious additive cardiovascular effects, though individuals sensitive to caffeine should still moderate intake.

Q: Are these legal to possess in the US? A: NA-Semax and NA-Selank are not FDA-approved and are sold as research chemicals. They are not controlled substances at the federal level, but legal frameworks vary by state. Importing finished sprays for personal use sits in a regulatory gray area — research local rules before purchasing.

Related Content

• Cerebrolysin Protocol
• Cognitive Peptide Stack
• Beginner's Stack Guide
• FDA Status Guide
• COA Reading Guide

Disclaimer: This content is for educational purposes only and is not medical advice. NA-Semax and NA-Selank are research compounds and are not FDA-approved for human use. The counterfeit rate in the unregulated market is high; verify any source carefully. Consult a licensed healthcare provider before starting any peptide protocol, especially if you have a psychiatric condition or take prescription medications.

Source: https://peptides.nyc/learn/na-semax-selank-protocol